This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
healthcare: Archive
These Top 4 Women-Run Company Stocks Are Quietly Beating the Market
by Shrabana Mukherjee
These women-run company stocks offer high growth and stability.
ACNPositive Net Change MCKPositive Net Change ELPositive Net Change ADBEPositive Net Change CNCNegative Net Change BMBLNegative Net Change
healthcare internet medical medical-devices tech-stocks thematic
CVS vs. Amazon: Healthcare Battle Continues- Which Stock to Buy Now?
by Urmimala Biswas
CVS surges with a 56% YTD return and an integrated care model, as AMZN bets on tech and logistics to reshape healthcare.
AMZNPositive Net Change CVSPositive Net Change
healthcare medical retail smart-health
BTSG vs. OPCH: Which Home Infusion Stock is a Better Buy Now?
by Urmimala Biswas
BTSG surges with 33% infusion growth and stronger EPS gains, making it a more compelling pick than OPCH right now.
OPCHPositive Net Change PLTRPositive Net Change BTSGPositive Net Change
earnings-estimates-revisions earnings-outlook earnings-report healthcare hospitals medical smart-health
TEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now?
by Urmimala Biswas
GH gains ground with stronger guidance, improving margin and Reveal's breakout as TEM scales fast but stays unprofitable.
AZNNegative Net Change GHPositive Net Change TEMPositive Net Change
artificial-intelligence biotechnology cancer earnings-outlook healthcare medical
CVS Surges on Regulatory Relief, Medicare Advantage Push: Time to Buy?
by Urmimala Biswas
CVS surges 53.7% YTD as regulatory relief, strong execution and Medicare Advantage momentum fuel investor confidence.
CVSPositive Net Change HLFPositive Net Change WBANegative Net Change
earnings-outlook healthcare medical retail
CRISPR Therapeutics Gains 14% in a Month: How to Play the Stock?
by Sundeep Ganoria
CRSP surges 14% on encouraging CTX310 data and growing Casgevy sales, despite early-stage pipeline risks.
VRTXPositive Net Change BEAMPositive Net Change NTLAPositive Net Change CRSPPositive Net Change
biotechs cancer crispr gene-editing gene-therapy healthcare medical
BrightSpring Soars to All-Time High on Quality Strength: Still a Buy?
by Urmimala Biswas
BTSG stock hits an all-time high with a 120% gain as soaring quality ratings and strong Q1 results fuel investor confidence.
AMEDPositive Net Change OPCHPositive Net Change BTSGPositive Net Change
earnings-outlook earnings-report healthcare medical medical-devices
Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today?
by Urmimala Biswas
Tempus AI surges 12.5% on new AI tools, a $200M AstraZeneca deal, and clinical data expansion- but is it time to buy?
AZNNegative Net Change IRTCNegative Net Change SOPHNegative Net Change TEMPositive Net Change
artificial-intelligence earnings-report healthcare medical medical-devices smart-health
Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks
by Urmimala Biswas
BSX, ABBV, AMGN and DXCM are tapping into the aging boom with cutting-edge tech, chronic care drugs and senior-focused innovations.
BSXPositive Net Change AMGNPositive Net Change DXCMNegative Net Change ABBVNegative Net Change CTREPositive Net Change CHCTPositive Net Change
biotechnology biotechs healthcare medical medical-devices pharmaceuticals
UnitedHealth Declines 40.4% YTD: Here's Why it's Still Not a Bargain
by Kaibalya Pravo Dey
UNH shares have plunged YTD, but regulatory risks, cost pressures and earnings downgrades keep it far from a bargain.
UNHPositive Net Change HUMNegative Net Change ELVNegative Net Change
healthcare hmo insurance medical
CVS or Cigna: Which Diversified Healthcare Stock Should You Own Now?
by Urmimala Biswas
CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare strategy.
CINegative Net Change CVSPositive Net Change
e-commerce earnings-outlook earnings-report earnings-streak earnings-surprise healthcare retail smart-health
Tempus AI vs. Butterfly: Which AI Health Tech Stock is the Better Buy?
by Urmimala Biswas
BFLY outpaces TEM with stronger upside, leaner valuation, and expanding global reach in AI-powered diagnostics.
AZNNegative Net Change BFLYNegative Net Change TEMPositive Net Change
artificial-intelligence earnings-outlook earnings-report healthcare medical medical-devices smart-health
UnitedHealth vs. Elevance: Which Healthcare Stock Has More Upside?
by Kaibalya Pravo Dey
ELV outpaces UNH with stronger earnings, leaner costs and clearer guidance, making it the healthcare stock with more upside right now.
UNHPositive Net Change ELVNegative Net Change
healthcare hmo insurance medical
Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better?
by Urmimala Biswas
With both MDT & ABT focusing on their core strengths, the stage is set for a compelling comparison. Let's see which stock is poised for greater upside.
ABTPositive Net Change MDTPositive Net Change
dividend dividend-stocks dividend-yield earnings-outlook earnings-report healthcare medical medical-devices
After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?
by Urmimala Biswas
President Donald Trump's new executive order aiming to cut U.S. drug prices could benefit Tempus AI.
AZNNegative Net Change IRTCNegative Net Change SOPHNegative Net Change TEMPositive Net Change
artificial-intelligence healthcare medical medical-devices smart-health
Should I Buy UnitedHealth Stock Now That it's Half-Off?
by David Bartosiak
UnitedHealth has been in serious trouble as of late. With the stock cut in half, is now the time to buy?
UNHPositive Net Change
healthcare
CVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?
by Urmimala Biswas
CVS' pharmacy segment continues to lead the industry, processing over 1.7 billion prescriptions annually while delivering high medication adherence.
UNHPositive Net Change CINegative Net Change CVSPositive Net Change HLFPositive Net Change WBANegative Net Change
earnings-outlook earnings-report healthcare medical medical-devices retail
Abbott Outpaces Peers Defying Tariff Woes: Is ABT Stock a Smart Buy?
by Urmimala Biswas
Despite trade policy challenges, Abbott's global footprint and 90 manufacturing sites offer flexibility to manage regional risks and reroute supply chains.
ABTPositive Net Change BSXPositive Net Change MDTPositive Net Change
earnings-outlook earnings-report healthcare medical medical-devices
Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings?
by Urmimala Biswas
TEM's Genomics unit is expected to report strong growth for the first quarter, banking on continued unit growth pick-up.
TXGNo Net Change SOPHNegative Net Change TEMPositive Net Change
artificial-intelligence earnings-estimates-revisions earnings-outlook earnings-preview earnings-report earnings-streak earnings-surprise healthcare medical-devices
Tariffs Cast a Shadow on Abbott's 2025 View: Time to Sell ABT Stock?
by Urmimala Biswas
With certain devices being imported into the United States from overseas, tariff-induced cost pressure is set to rise for Abbott from the third quarter of 2025.
ABTPositive Net Change BSXPositive Net Change MDTPositive Net Change
earnings-outlook earnings-report healthcare medical medical-devices
Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?
by Urmimala Biswas
TEM stock rises for three successive days. Should you expect more upside ahead, or is it time to dump Tempus AI?
AZNNegative Net Change IRTCNegative Net Change SOPHNegative Net Change TEMPositive Net Change
artificial-intelligence healthcare medical medical-devices pharmaceuticals
Wall Street Shaken as UnitedHealth Tanks Since Q1 Miss: Buy the Dip?
by Kaibalya Pravo Dey
From a valuation perspective, UNH appears expensive compared to its peers despite the drop in price.
UNHPositive Net Change HUMNegative Net Change ELVNegative Net Change
earnings-outlook earnings-surprise healthcare hmo insurance medical
CVS Soars 53% in Q1: Time to Buy the Stock Ahead of Earnings Release?
by Urmimala Biswas
Caremark, CVS Health's PBM business, is expected to have continued to play a vital role in offsetting the rising cost of branded drugs during the first quarter.
CVSPositive Net Change HLFPositive Net Change WBANegative Net Change
earnings-estimates-revisions earnings-outlook earnings-preview earnings-report earnings-streak earnings-surprise healthcare medical medical-devices retail
Should You Buy Boston Scientific Stock Ahead of Q1 Earnings?
by Urmimala Biswas
Banking on robust above-market growth across all business units, BSX is expected to have witnessed strong international momentum in the first quarter.
ABTPositive Net Change BSXPositive Net Change MDTPositive Net Change
earnings-estimates-revisions earnings-outlook earnings-preview earnings-streak earnings-surprise healthcare medical medical-devices
CVS Health vs. UnitedHealth: Which Healthcare Stock Has More Upside?
by Urmimala Biswas
CVS Health and UnitedHealth are two of the top companies leading the S&P 500 chart YTD. But which is the better investment now? Let's take a closer look.
UNHPositive Net Change CVSPositive Net Change
healthcare hospitals insurance medical medical-devices